NASDAQ:NUVB News 2 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio shares fell 17.7% to $6.62 Monday after announcing a licensing deal with Eisai and releasing initial sales data for its lung-cancer drug. Eisai will pay €50 million upfront for rights outside the U.S., China, and Japan, with further milestone payments possible. Fourth-quarter Ibtrozi sales met estimates, but investors appeared cautious on future prescription growth.

12 January 2026

Biotechnology·Earnings Reports·NASDAQ:NUVB·Stock Market·TSX:4523

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio shares fell 4.7% to $8.05 Friday afternoon, underperforming biotech peers. UBS began coverage at Neutral with a $10 target, while RBC raised its target to $9 and reiterated Outperform. CEO David Hung is set to present at the J.P. Morgan Healthcare Conference on Jan. 13. Investors await early March results for updates on IBTROZI’s launch and pipeline spending.

9 January 2026

NASDAQ:NUVB·Stock Market

Nuvation Bio stock today: NUVB slides nearly 7% as early gains fade

Nuvation Bio shares fell 6.8% to $8.35 in Friday afternoon trading, reversing an early jump and underperforming major biotech ETFs. About 3.3 million shares traded hands. No new regulatory filings were reported. Investors are awaiting updates on IBTROZI’s commercial launch and clinical milestones.

2 January 2026

Biotechnology·NASDAQ:NUVB·Stock Market

Shell stock: What to watch after PwC audit switch and Kazakhstan warning as buybacks roll on

7 February 2026

Shell shares closed up 0.18% at 2,774.5 pence in London on Friday. The company named PwC as auditor from 2027, replacing EY after compliance issues. CEO Wael Sawan said Shell will pause new investments in Kazakhstan due to legal disputes. Shell also disclosed further share buybacks this week.

Reliance Industries share price in focus after Australia consumer deal ahead of Monday trade

7 February 2026

Reliance Industries shares closed up 0.5% at 1,450.80 rupees on Friday after its consumer unit bought a majority stake in Australia’s Goodness Group Global. The deal’s financial terms were not disclosed. Reliance remains about 10% below its 52-week high, with trading volume at half the 50-day average. Indian markets reopen Monday.

China Mobile Class A (600941) price: BeiDou satellite SMS roll-out in focus before Shanghai reopens

7 February 2026

China Mobile’s Shanghai-listed shares closed at 95.11 yuan, down 0.26% Friday, as the Shanghai Composite Index slipped 0.25%. The company and rivals launched BeiDou satellite texting for use without ground networks. A new tax rule raises VAT on telecom services to 9% from 6% starting Jan. 1, 2026, which China Mobile said will impact revenue and profit.

Bank of China A Shares Slip Into Monday After Anti-Graft Headline — What to Watch Next

7 February 2026

Bank of China A shares closed at 5.35 yuan in Shanghai Friday, down 0.93%. State media reported former vice president Lin Jingzhen was expelled from the Communist Party for “serious violations of discipline and law”. No details of the alleged misconduct were released. The stock is down about 6.6% year-to-date.

NASDAQ:NUVB News 2 January 2026 - 12 January 2026

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

Nuvation Bio stock falls as UBS starts coverage; NUVB investors eye JPM conference next week

Nuvation Bio stock today: NUVB slides nearly 7% as early gains fade

Stock Market Today

Shell stock: What to watch after PwC audit switch and Kazakhstan warning as buybacks roll on

Reliance Industries share price in focus after Australia consumer deal ahead of Monday trade

China Mobile Class A (600941) price: BeiDou satellite SMS roll-out in focus before Shanghai reopens

Bank of China A Shares Slip Into Monday After Anti-Graft Headline — What to Watch Next